The European Heart Journal looked at 3 million US patients, with twenty-eight different cancers for more than 40 years. The researchers have said that the enhancement in the numbers of surviving cancer means more attention should be focused on cardiovascular risk. UK experts say that doctors should be more conscious and monitor patients accordingly. Among the studies, 3.23 million cancer patients, 38% died from cancer, and 11% of them died from cardiovascular disease, that is known as CVD, of which three-quarters were from heart disease. The ratio of cancer survivors dying from CVD was highest in those with a disease of the bladder, prostate, larynx, womb, breast, and bowel. The risk in the first stage could be stated by the effects of chemotherapy or radiation treatment on people’s bodies. Still, rates unresisted to be higher than those in the general population. The study stated cancer patients were perpetually at high risk.
Dr. Nicholas Zaorsky, who is a radiation oncologist, from Penn State Cancer Institute, who led the study, stated that information about the risk could help patients to live more healthily in the long term. He also said that growing awareness of this risk might haste cancer survivors to fulfill healthy lifestyle behaviors that reduce not only their risk of cardiovascular disease but also the risk of cancer recapitulation. Martin Ledwick, nurse of the head cancer information at Cancer Research UK, has stated that doctors should be conscious of this research as it suggests cancer patients require to be monitored more closely after the treatment for heart disease and stroke. But it doesn’t disclose why some cancer patients may be at the upper risk of dying from cardiovascular.
Professor Metin Avkiran, who is the associate medical director at the British Heart Foundation, has stated that the study provided further evidence that, compared with the general population, cancer survivors are at much higher risk of death from circulatory and heart disease. He also added that more researches are required to understand why this is and whether factors other than the common damaging effects of some anti-cancer treatments on the blood vessels and heart are at play.